New dilemmas in small-cell lung cancer TNM clinical staging
Author(s) -
Paul Zarogoulidis,
Latsios,
Eleftheriadou,
Boutsikou,
Darwiche,
Wolfgang HohenforstSchmidt,
Κonstantinos Porpodis,
Theodoros Kontakiotis,
Antoniou
Publication year - 2013
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s44201
Subject(s) - medicine , lung cancer , gastroenterology , tnm staging system , oncology , stage (stratigraphy) , statistical significance , disease , cancer , neoplasm staging , paleontology , biology
Many patients with limited disease (LD) behave similarly to those with extensive disease (ED) from a prognostic point of view. On the other hand, a proportion of patients with ED small-cell lung cancer (SCLC) behave similarly to those with LD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom